NYSE:PACS

PACS Group (PACS) Stock Price, News & Analysis

$28.37
+1.46 (+5.43%)
(As of 05/15/2024 ET)
Today's Range
$26.97
$28.57
50-Day Range
N/A
52-Week Range
$22.61
$28.57
Volume
635,586 shs
Average Volume
586,446 shs
Market Capitalization
$4.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.50

PACS Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.3% Upside
$31.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.12mentions of PACS Group in the last 14 days
Based on 35 Articles This Week
Insider Trading
Selling Shares
$33.75 M Sold Last Quarter
Proj. Earnings Growth
23.18%
From $1.51 to $1.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.93 out of 5 stars

Medical Sector

420th out of 928 stocks

Skilled Nursing Care Facilities Industry

2nd out of 2 stocks

About PACS Group

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

PACS Stock Price History

PACS Stock News Headlines

PACS Group, Inc.'s (NYSE:PACS) Quiet Period To Expire on May 21st
PACS Group, Inc. Reports First Quarter 2024 Results
PACS Group (PACS) Set to Announce Earnings on Monday
See More Headlines
Receive PACS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PACS Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/15/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Skilled nursing care facilities
Sub-Industry
N/A
Fax
N/A
Employees
32,433
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.50
High Stock Price Target
$32.00
Low Stock Price Target
$27.00
Potential Upside/Downside
+13.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4.04 billion
Optionable
Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Jason Murray (Age 44)
    Co-Founder, CEO & Chairman
    Comp: $5.06M
  • Mr. Mark Hancock (Age 48)
    Co-Founder & Exec. Vice Chairman
    Comp: $5.06M
  • Mr. Joshua Jergensen (Age 39)
    Pres & COO
    Comp: $8.3M
  • Mr. Derick Apt (Age 40)
    Chief Financial Officer
    Comp: $5.87M
  • Mr. Peter Sanford (Age 38)
    Pres of Providence Admin. Consulting Services, Inc.
    Comp: $5.61M
  • Ms. Michelle Lewis (Age 47)
    Chief Accounting Officer
  • Mr. John Todd Mitchell Esq. (Age 48)
    Chief Legal Officer & Sec.
  • Mr. Joseph Lee (Age 45)
    Chief Compliance Officer

PACS Stock Analysis - Frequently Asked Questions

Should I buy or sell PACS Group stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PACS Group in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PACS shares.
View PACS analyst ratings
or view top-rated stocks.

What is PACS Group's stock price target for 2024?

6 brokers have issued 12-month price targets for PACS Group's stock. Their PACS share price targets range from $27.00 to $32.00. On average, they anticipate the company's stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 9.3% from the stock's current price.
View analysts price targets for PACS
or view top-rated stocks among Wall Street analysts.

How have PACS shares performed in 2024?

PACS Group's stock was trading at $24.00 at the beginning of 2024. Since then, PACS stock has increased by 18.1% and is now trading at $28.35.
View the best growth stocks for 2024 here
.

When is PACS Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our PACS earnings forecast
.

What guidance has PACS Group issued on next quarter's earnings?

PACS Group issued an update on its FY 2024 earnings guidance on Tuesday, May, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.7 billion-$3.8 billion, compared to the consensus revenue estimate of $3.7 billion.

When did PACS Group IPO?

PACS Group (PACS) raised $450 million in an initial public offering on Thursday, April 11th 2024. The company issued 21,428,572 shares at a price of $21.00 per share.

When does the company's quiet period expire?

PACS Group's quiet period expires on Tuesday, May 21st. PACS Group had issued 21,428,572 shares in its initial public offering on April 11th. The total size of the offering was $450,000,012 based on an initial share price of $21.00. During the company's quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of PACS Group?

Shares of PACS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:PACS) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners